No Data
No Data
2024 Annual Report of Qingdao Weilan Biology Co., Ltd.
Summary of the 2024 Annual Report of Qingdao Weilan Biology Co., Ltd
Announcement of the main operating data of Qingdao Weilan Biology Co., Ltd. for the first quarter of 2025
Qingdao Weilan Biology Co., Ltd. Report for the first quarter of 2025
Express News | Qingdao Vland Biotech INC.: In the first quarter of 2025, the net income was 9.5768 million yuan, a year-on-year decrease of 24.73%.
Qingdao Vland Biotech INC. (603739.SH): The export revenue to the USA market accounts for a very low proportion.
On April 15, Gelonghui reported that Qingdao Vland Biotech INC. (603739.SH) stated on the investor interaction platform that the company's products primarily export to countries and regions including the Philippines, Vietnam, Brazil, and Bulgaria. As of now, the company's business is mainly focused on the domestic market, with domestic business revenue accounting for about 92%, and the export revenue to the USA market being very low. Adjustments to the USA tariff policy will not have a significant impact on the company's operation.